How to build a PhysioPD™ model
by
Rebecca Baillie, PhD
Rosa & Co
June 20, 2011
12:00 - 1:00 pm EDT
You are invited to attend Dr. Baillie's webinar How to build a PhysioPD model
on June 20, 2011 at 12:00 pm EDT (GMT -5:00). Dr. Baillie's talk will explore
the development of a PhysioPD model from scoping to incorporation of the
mathematics. She will focus on how the models are designed, the science
integrated, and the mathematics implemented into the selected pathways as well
as the parameters and rates.
Dr. Baillie's presentation is a part of the monthly world-wide webinar series
“Impact of Modeling & Simulation in Drug Development” hosted by Rosa & Co. LLC.
The purpose of the “Impact” series is to foster the use of M&S activities in
all phases of drug development by illustrating the advantages and enhancing the
applicability of M&S in product discovery, development, and marketing programs.
The series is intended for drug development project team members from discovery
to phase 4 clinical trials. This includes pharmacologists, ADME scientists,
PK/PD modelers, clinical pharmacologists, clinical development team members,
regulatory affairs specialists, and other interested professionals.
Register for this free webinar at www.rosaandco.com/webinar. After registering
you will receive a confirmation email containing information about joining the
webinar. More information about the webinar series, an archive of past
webinars, and a list of future webinar speakers may be found at
www.rosaandco.com/webinar.
Please allow 5-10 minutes for a Java applet to be installed on your computer
prior to joining our webinar series for the first time.
Toufigh Gordi, PhD
President, PK/PD and Clinical Pharmacology Services
Rosa & Co. LLC: www.rosaandco.com
E-mail: [email protected]
Tel.: 408-480-7314
Fax: 408-370-9810
The information contained in this e-mail message, e-mail message sequence,
and/or any enclosures is confidential, and it may be privileged and protected
from unauthorized use and/or disclosure. If you are not the intended recipient,
any use, dissemination, distribution, or copying is strictly prohibited. If you
received this e-mail in error, PLEASE NOTIFY THE SENDER immediately and destroy
this message, any enclosures, and any copies of the message and/or the
enclosures. Thank you.